×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Performance Evaluation Reports Ivd Medical Devices

Performance Evaluation Reports (PER) for IVD and Medical Devices

Every IVD device is required to have a Performance Evaluation Report in accordance with the EU In Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR) (PER). The three pillars of PERs are clinical performance, analytical performance, and scientific validity.

For IVD makers, gathering data to adequately address each pillar must be a top concern. Notified bodies won’t work with manufacturers that can’t show that they have procedures in place for IVDR compliance because of the pressure and resource constraints they are under.

Performance Evaluation Report

Current Challenges Related to PER

Lack of expertise in authoring and updating Performance Evaluation Report
Scarcity of qualified writers and evaluators with profound knowledge on In Vitro diagnostics
Lack of effective planning to compile and submit the PER’s to Notified bodies meeting regulatory requirements
Lack of management practices aimed at timelines meeting regulatory changes

Artixio's Expertise ​

Compliance consulting services company
Regulatory champions with experience in authoring Performance Evaluation Reports for In-Vitro Diagnostics (IVD)
Compliance consulting services company
Clinical and Medical Professionals with decades of experience in evaluating clinical reports
Compliance consulting services company
Notified Bodies experience to precisely recommend strategy for Right First Time reports
Compliance consulting services company
Streamlined Project Management to meet regulatory timelines

Performance Evaluation of In-Vitro Diagnostics

Process of Preparing Performance Evaluation Report

Artixio is helping IVD manufacturers globally with preparation of Performance Evaluation Report for their products.

We look forward to hearing from you.

Specialized Registration
Services Across Multiple Industries

Regulatory and compliance expert – Artixio

Pharmaceuticals

Medical device regulatory services – Artixio

MedTech

Cosmetics regulatory consulting – Artixio

Cosmetics

Nutrition regulatory consulting – Artixio

Nutrition

Biologics regulatory consulting – Artixio

Biologics

Veterinary regulatory consulting – Artixio

Veterinary

Expert Regulatory Services To Streamline Compliance

GxP Compliance Regulatory monitoring services
Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India Artixio – Regulatory affairs consulting expert

India

Singapore Artixio – Regulatory affairs consulting expert

Singapore

Mexico Artixio – Regulatory affairs consulting expert

Mexico

Brazil Artixio – Regulatory affairs consulting expert

Brazil

Vietnam Artixio – Regulatory affairs consulting expert

Vietnam

Malaysia Artixio – Regulatory affairs consulting expert

Malaysia

Argentina Artixio – Regulatory affairs consulting expert

Argentina

Colombia Artixio – Regulatory affairs consulting expert

Colombia

Taiwan Artixio – Regulatory affairs consulting expert

Taiwan

China Artixio – Regulatory affairs consulting expert

China

Europe Artixio – Regulatory affairs consulting expert

European

Thailand Artixio – Regulatory affairs consulting expert

Thailand

Indonesia Artixio – Regulatory affairs consulting expert

Indonesia

Philippines Artixio – Regulatory affairs consulting expert

Philippines

USA Artixio – Regulatory affairs consulting expert

USA

Japan Artixio – Regulatory affairs consulting expert

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

HSA Guidance on Class 2 CTGTP Registration in Singapore

HSA Guidance on Class

Advanced medicines, such as cell, gene, and tissue-engineered therapies, are revolutionizing modern medicine. In...

February 24, 2026
HSA Singapore Investigational Product Management Guidance

HSA Singapore Investigational Product

For locally registered products in Singapore, the management of investigational product (IP) for clinical...

February 23, 2026
Strategic Criteria for Selecting a Regulatory Consultant in Thailand

Strategic Criteria for Selecting

All industries in Thailand, including cosmetics, food, medical devices, and nutrition, develop very fast,...

January 28, 2026

Get in touch

×